Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation

BACKGROUND: The clinical use of chromatin-modulating drugs, such as histone deacetylase inhibitors, for the treatment of bone marrow failure and hematopoietic malignancies has increased dramatically over the last few years. Nonetheless, little is currently known concerning their effects on myelopoie...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bartels, Marije, Geest, Christian R., Bierings, Marc, Buitenhuis, Miranda, Coffer, Paul J.
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2010
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895027/
https://ncbi.nlm.nih.gov/pubmed/20107159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.008870
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares